Charles Michael Lombard, MD
Pathology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 7
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
7 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lombard’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
7 of 7 plans
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G40301 · Current
Licensed to practise in California · since 1979 · expires 2027-07-31 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$52,757
Medicare paid this office $52,757 for 250 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 170 | $14,338 | $34 |
| Special stained specimen slides to examine tissue, each additional procedure | 91 | $8,336 | $25 |
| Pathology examination of tissue using a microscope, high complexity | 46 | $6,915 | $133 |
| Pathology examination of tissue using a microscope, moderately high complexity | 45 | $5,803 | $75 |
| Special stained specimen slides to examine tissue, initial procedure | 121 | $4,512 | $32 |
See all 10 services
| Pathology examination of tissue using a microscope, intermediate complexity | 170 | $14,338 | $34 |
| Special stained specimen slides to examine tissue, each additional procedure | 91 | $8,336 | $25 |
| Pathology examination of tissue using a microscope, high complexity | 46 | $6,915 | $133 |
| Pathology examination of tissue using a microscope, moderately high complexity | 45 | $5,803 | $75 |
| Special stained specimen slides to examine tissue, initial procedure | 121 | $4,512 | $32 |
| Microscopic genetic analysis of tumor, manual | 84 | $4,027 | $37 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 50 | $3,741 | $75 |
| Special stained specimen slides to identify organisms including interpretation and report | 43 | $2,718 | $24 |
| Special stained specimen slides to examine tissue including interpretation and report | 32 | $504 | $11 |
| Genetic sequencing localization, initial procedure | 12 | $471 | $39 |
Who their Medicare patients are
250 Original Medicare patients in 2024. Average age 74 · Under 65 4% · 85 and older 10% · Women 54% · Also on Medicaid 21% · Health risk score 1.74. Above the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 75% · Cancer 74% · Coronary heart disease 39% · COPD 33% · Diabetes 31% · Chronic kidney disease 28% · Atrial fibrillation 28% · Heart failure 20% · Depression 17% · Stroke 8%.
The office billed $644,182, Medicare allowed $66,228 and paid $52,757; for 1,381 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 250 | 1,381 | 74 | 1.74 | $644,182 | $52,757 |
| 2023 | 123 | 728 | 74 | 1.49 | $329,528 | $29,308 |
| 2022 | 456 | 1,552 | 78 | 1.70 | $184,248 | $46,148 |
| 2021 | 1,223 | 5,123 | 76 | 1.44 | $657,061 | $163,286 |
| 2020 | 1,145 | 4,960 | 75 | 1.46 | $642,725 | $164,633 |
| 2019 | 1,482 | 6,386 | 76 | 1.37 | $856,067 | $218,902 |
| 2018 | 1,388 | 5,656 | 75 | 1.32 | $785,138 | $196,007 |
| 2017 | 1,271 | 5,476 | 75 | 1.38 | $773,288 | $195,414 |
| 2016 | 1,206 | 4,654 | 75 | 1.28 | $661,613 | $167,422 |
| 2015 | 1,116 | 3,904 | 75 | 1.33 | $582,107 | $136,856 |
| 2014 | 1,144 | 3,980 | 75 | 1.33 | $572,243 | $122,869 |
| 2013 | 1,038 | 3,172 | 74 | 1.28 | $471,091 | $108,853 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Pathology examination of tissue using a microscope, intermediate complexity | 84 | $8,129 | $34 |
| Pathology examination of tissue using a microscope, high complexity | 33 | $5,626 | $134 |
| Pathology examination of tissue using a microscope, moderately high complexity | 38 | $4,926 | $76 |
| Special stained specimen slides to examine tissue, each additional procedure | 38 | $3,425 | $26 |
| Special stained specimen slides to examine tissue, initial procedure | 56 | $2,046 | $32 |
| Microscopic genetic analysis of tumor, manual | 43 | $1,836 | $38 |
| Special stained specimen slides to identify organisms including interpretation and report | 19 | $1,406 | $24 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 11 | $846 | $77 |
| Special stained specimen slides to examine tissue including interpretation and report | 23 | $513 | $11 |
2022: 17 services
| Pathology examination of tissue using a microscope, intermediate complexity | 145 | $9,598 | $35 |
| Protein measurement, serum | 225 | $6,145 | $16 |
| Special stained specimen slides to examine tissue, each additional procedure | 46 | $6,109 | $26 |
| Pathology examination of tissue using a microscope, moderately high complexity | 43 | $5,815 | $77 |
| Microscopic genetic analysis of tumor, manual | 28 | $3,514 | $39 |
| Special stained specimen slides to examine tissue, initial procedure | 78 | $3,286 | $32 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 31 | $2,039 | $33 |
| Pathology examination of tissue using a microscope, high complexity | 13 | $1,913 | $137 |
| Cell examination of specimen, selective cellular enhancement technique | 26 | $716 | $26 |
| Protein measurement, body fluid | 42 | $690 | $16 |
| Immunologic analysis technique on serum (immunofixation) | 32 | $690 | $16 |
| Genetic sequencing localization, initial procedure | 11 | $408 | $37 |
| Special stained specimen slides to examine tissue including interpretation and report | 18 | $405 | $11 |
| Preparation of tissue for examination by removing any calcium present | 20 | $221 | $11 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 13 | $202 | $16 |
| Pathology examination of tissue using a microscope, moderately low complexity | 16 | $181 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 24 | $114 | $4 |
2021: 26 services
| Pathology examination of tissue using a microscope, intermediate complexity | 611 | $43,397 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 172 | $26,613 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 118 | $15,699 | $79 |
| Microscopic genetic analysis of tumor, manual | 120 | $12,097 | $40 |
| Protein measurement, serum | 345 | $11,471 | $17 |
| Special stained specimen slides to examine tissue, initial procedure | 254 | $11,042 | $33 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 70 | $5,687 | $79 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 70 | $4,588 | $36 |
| Pathology examination of tissue using a microscope, high complexity | 28 | $4,347 | $140 |
| Bone marrow, smear interpretation | 63 | $2,947 | $46 |
| Genetic sequencing localization, initial procedure | 65 | $2,905 | $41 |
| Pathology examination of specimen during surgery, first tissue block | 33 | $2,625 | $60 |
| Special stained specimen slides to identify organisms including interpretation and report | 55 | $2,489 | $25 |
| Evaluation of fine needle aspirate with interpretation and report | 27 | $2,454 | $66 |
| Genetic sequencing localization, each additional procedure | 53 | $1,952 | $33 |
| Special stained specimen slides to examine tissue including interpretation and report | 80 | $1,865 | $11 |
| Protein measurement, body fluid | 74 | $1,336 | $17 |
| Cell examination of specimen, selective cellular enhancement technique | 43 | $1,202 | $26 |
| Preparation of tissue for examination by removing any calcium present | 90 | $1,148 | $12 |
| Immunologic analysis technique on serum (immunofixation) | 52 | $1,079 | $17 |
| Pathology examination of tissue using a microscope, moderately low complexity | 61 | $692 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 97 | $464 | $4 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 26 | $445 | $17 |
| Examination of archival tissue for genetic analysis | 21 | $393 | $19 |
| Cell examination of specimen, concentration technique | 14 | $388 | $22 |
| Pathology examination of tissue using a microscope | 13 | $84 | $6 |
2020: 27 services
| Pathology examination of tissue using a microscope, intermediate complexity | 606 | $46,039 | $36 |
| Special stained specimen slides to examine tissue, each additional procedure | 187 | $26,736 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 112 | $14,603 | $82 |
| Microscopic genetic analysis of tumor, manual | 115 | $11,799 | $41 |
| Special stained specimen slides to examine tissue, initial procedure | 250 | $11,137 | $35 |
| Protein measurement, serum | 310 | $10,057 | $17 |
| Pathology examination of tissue using a microscope, high complexity | 30 | $5,214 | $145 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 73 | $4,958 | $37 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 58 | $4,807 | $80 |
| Evaluation of fine needle aspirate with interpretation and report | 29 | $3,351 | $70 |
| Special stained specimen slides to identify organisms including interpretation and report | 79 | $3,106 | $26 |
| Pathology examination of specimen during surgery, first tissue block | 35 | $3,041 | $62 |
| Genetic sequencing localization, initial procedure | 62 | $2,799 | $42 |
| Bone marrow, smear interpretation | 56 | $2,684 | $47 |
| Special stained specimen slides to examine tissue including interpretation and report | 83 | $1,965 | $12 |
| Genetic sequencing localization, each additional procedure | 49 | $1,870 | $33 |
| Protein measurement, body fluid | 72 | $1,323 | $17 |
| Immunologic analysis technique on serum (immunofixation) | 57 | $1,092 | $17 |
| Preparation of tissue for examination by removing any calcium present | 83 | $1,057 | $12 |
| Cell examination of specimen, selective cellular enhancement technique | 32 | $868 | $27 |
| Pathology examination of specimen during surgery, each additional tissue block | 17 | $617 | $31 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 32 | $616 | $18 |
| Evaluation of fine needle aspirate | 12 | $572 | $36 |
| Pathology examination of tissue using a microscope, moderately low complexity | 48 | $543 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 88 | $405 | $4 |
| Examination of archival tissue for genetic analysis | 19 | $364 | $19 |
| Blood smear interpretation by physician with written report | 12 | $265 | $22 |
2019: 31 services
| Pathology examination of tissue using a microscope, intermediate complexity | 840 | $61,327 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 222 | $31,688 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 188 | $25,411 | $80 |
| Microscopic genetic analysis of tumor, manual | 154 | $17,808 | $41 |
| Special stained specimen slides to examine tissue, initial procedure | 295 | $12,865 | $34 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 141 | $10,535 | $37 |
| Protein measurement, serum | 280 | $8,125 | $17 |
| Pathology examination of tissue using a microscope, high complexity | 47 | $7,824 | $142 |
| Special stained specimen slides to identify organisms including interpretation and report | 150 | $5,921 | $26 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 55 | $4,641 | $80 |
| Pathology examination of specimen during surgery, first tissue block | 51 | $3,771 | $61 |
| Genetic sequencing localization, initial procedure | 71 | $3,113 | $42 |
| Bone marrow, smear interpretation | 62 | $2,984 | $47 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 16 | $2,727 | $170 |
| Special stained specimen slides to examine tissue including interpretation and report | 120 | $2,598 | $11 |
| Evaluation of fine needle aspirate with interpretation and report | 26 | $2,592 | $68 |
| Genetic sequencing localization, each additional procedure | 54 | $2,034 | $33 |
| Cell examination of specimen, selective cellular enhancement technique | 66 | $1,858 | $27 |
| Protein measurement, body fluid | 67 | $1,406 | $17 |
| Preparation of tissue for examination by removing any calcium present | 99 | $1,247 | $12 |
| Pathology examination of tissue using a microscope, moderately low complexity | 87 | $1,011 | $11 |
| Immunologic analysis technique on serum (immunofixation) | 51 | $996 | $17 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 32 | $638 | $17 |
| Pathology examination of specimen during surgery, each additional tissue block | 16 | $634 | $30 |
| Evaluation of fine needle aspirate | 13 | $560 | $35 |
| Pathology examination of specimen during surgery | 15 | $547 | $34 |
| Examination of archival tissue for genetic analysis | 25 | $469 | $18 |
| Pathology examination of tissue using a microscope, limited examination | 104 | $453 | $4 |
| Blood smear interpretation by physician with written report | 18 | $418 | $23 |
| Cell examination of specimen, concentration technique | 12 | $260 | $22 |
| Pathology examination of tissue using a microscope | 14 | $91 | $7 |
2018: 28 services
| Pathology examination of tissue using a microscope, intermediate complexity | 805 | $61,266 | $35 |
| Special stained specimen slides to examine tissue, each additional procedure | 188 | $24,585 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 174 | $24,157 | $80 |
| Microscopic genetic analysis of tumor, manual | 125 | $14,027 | $43 |
| Special stained specimen slides to examine tissue, initial procedure | 270 | $11,644 | $34 |
| Pathology examination of tissue using a microscope, high complexity | 46 | $7,943 | $142 |
| Protein measurement, serum | 243 | $6,810 | $16 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 94 | $5,978 | $37 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 67 | $5,544 | $79 |
| Special stained specimen slides to identify organisms including interpretation and report | 124 | $5,156 | $25 |
| Pathology examination of specimen during surgery, first tissue block | 43 | $3,404 | $61 |
| Cell examination of specimen, selective cellular enhancement technique | 88 | $3,294 | $27 |
| Evaluation of fine needle aspirate with interpretation and report | 33 | $2,653 | $68 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 14 | $2,144 | $153 |
| Genetic sequencing localization, initial procedure | 45 | $2,017 | $42 |
| Bone marrow, smear interpretation | 44 | $1,986 | $45 |
| Special stained specimen slides to examine tissue including interpretation and report | 83 | $1,949 | $11 |
| Protein measurement, body fluid | 64 | $1,224 | $17 |
| Genetic sequencing localization, each additional procedure | 34 | $1,224 | $33 |
| Preparation of tissue for examination by removing any calcium present | 93 | $1,203 | $12 |
| Pathology examination of tissue using a microscope, moderately low complexity | 75 | $927 | $11 |
| Pathology examination of specimen during surgery, each additional tissue block | 19 | $840 | $30 |
| Pathology examination of specimen during surgery | 22 | $754 | $34 |
| Immunologic analysis technique on serum (immunofixation) | 30 | $553 | $17 |
| Evaluation of fine needle aspirate | 13 | $520 | $35 |
| Pathology examination of tissue using a microscope, limited examination | 103 | $434 | $4 |
| Examination of archival tissue for genetic analysis | 24 | $432 | $18 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 15 | $252 | $17 |
2017: 30 services
| Pathology examination of tissue using a microscope, intermediate complexity | 732 | $57,339 | $35 |
| Pathology examination of tissue using a microscope, moderately high complexity | 162 | $22,219 | $80 |
| Special stained specimen slides to examine tissue, each additional procedure | 169 | $20,984 | $26 |
| Microscopic genetic analysis of tumor, manual | 130 | $17,603 | $52 |
| Special stained specimen slides to examine tissue, initial procedure | 229 | $10,337 | $34 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 117 | $8,783 | $37 |
| Pathology examination of tissue using a microscope, high complexity | 52 | $8,227 | $142 |
| Protein measurement, serum | 249 | $7,444 | $16 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 30 | $5,049 | $168 |
| Pathology examination of specimen during surgery, first tissue block | 53 | $4,821 | $60 |
| Special stained specimen slides to identify organisms including interpretation and report | 105 | $4,312 | $25 |
| Cell examination of specimen, selective cellular enhancement technique | 107 | $3,505 | $26 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 37 | $3,414 | $83 |
| Evaluation of fine needle aspirate with interpretation and report | 32 | $2,836 | $68 |
| Bone marrow, smear interpretation | 45 | $2,116 | $46 |
| Genetic sequencing localization, initial procedure | 37 | $1,762 | $42 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 20 | $1,621 | $42 |
| Special stained specimen slides to examine tissue including interpretation and report | 71 | $1,586 | $11 |
| Protein measurement, body fluid | 79 | $1,373 | $17 |
| Pathology cytologic examination of specimen during surgery, initial site | 15 | $1,333 | $61 |
| Genetic sequencing localization, each additional procedure | 32 | $1,222 | $33 |
| Preparation of tissue for examination by removing any calcium present | 76 | $985 | $12 |
| Pathology examination of tissue using a microscope, moderately low complexity | 74 | $838 | $11 |
| Evaluation of fine needle aspirate | 19 | $831 | $35 |
| Immunologic analysis technique on serum (immunofixation) | 48 | $804 | $16 |
| Pathology examination of specimen during surgery | 22 | $753 | $34 |
| Pathology examination of specimen during surgery, each additional tissue block | 16 | $628 | $30 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 24 | $435 | $17 |
| Pathology examination of tissue using a microscope, limited examination | 82 | $363 | $4 |
| Pathology examination of tissue using a microscope | 17 | $122 | $7 |
2016: 28 services
| Pathology examination of tissue using a microscope, intermediate complexity | 691 | $48,552 | $35 |
| Pathology examination of tissue using a microscope, moderately high complexity | 141 | $21,290 | $79 |
| Special stained specimen slides to examine tissue, each additional procedure | 155 | $18,272 | $25 |
| Microscopic genetic analysis of tumor, manual | 103 | $14,122 | $51 |
| Special stained specimen slides to examine tissue, initial procedure | 214 | $9,114 | $34 |
| Protein measurement, serum | 250 | $6,972 | $17 |
| Pathology examination of tissue using a microscope, high complexity | 36 | $6,776 | $138 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 46 | $6,435 | $140 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 94 | $5,992 | $37 |
| Special stained specimen slides to identify organisms including interpretation and report | 104 | $3,952 | $26 |
| Pathology examination of specimen during surgery, first tissue block | 45 | $3,884 | $60 |
| Evaluation of fine needle aspirate with interpretation and report | 36 | $2,830 | $67 |
| Cell examination of specimen, selective cellular enhancement technique | 87 | $2,787 | $26 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 25 | $2,545 | $102 |
| Bone marrow, smear interpretation | 26 | $1,184 | $46 |
| Protein measurement, body fluid | 64 | $1,136 | $17 |
| Genetic sequencing localization, initial procedure | 22 | $1,120 | $41 |
| Special stained specimen slides to examine tissue including interpretation and report | 53 | $943 | $11 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 13 | $913 | $41 |
| Preparation of tissue for examination by removing any calcium present | 73 | $904 | $12 |
| Immunologic analysis technique on serum (immunofixation) | 48 | $852 | $16 |
| Pathology examination of specimen during surgery | 23 | $786 | $34 |
| Evaluation of fine needle aspirate | 20 | $725 | $35 |
| Genetic sequencing localization, each additional procedure | 17 | $601 | $32 |
| Pathology examination of tissue using a microscope, moderately low complexity | 44 | $509 | $11 |
| Pathology examination of specimen during surgery, each additional tissue block | 14 | $501 | $29 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 22 | $434 | $17 |
| Pathology examination of tissue using a microscope, limited examination | 69 | $293 | $4 |
2015: 25 services
| Pathology examination of tissue using a microscope, intermediate complexity | 670 | $52,094 | $35 |
| Pathology examination of tissue using a microscope, moderately high complexity | 131 | $17,738 | $78 |
| Special stained specimen slides to examine tissue, each additional procedure | 103 | $8,388 | $20 |
| Special stained specimen slides to examine tissue, initial procedure | 143 | $6,199 | $33 |
| Microscopic genetic analysis of tumor, manual | 54 | $6,198 | $50 |
| Protein measurement, serum | 183 | $5,945 | $17 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 32 | $5,403 | $169 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 70 | $4,575 | $35 |
| Special stained specimen slides to identify organisms including interpretation and report | 105 | $4,179 | $25 |
| Pathology examination of tissue using a microscope, high complexity | 30 | $4,163 | $139 |
| Evaluation of fine needle aspirate with interpretation and report | 43 | $4,030 | $66 |
| Pathology examination of specimen during surgery, first tissue block | 51 | $3,730 | $59 |
| Cell examination of specimen, selective cellular enhancement technique | 84 | $2,722 | $26 |
| Evaluation of fine needle aspirate | 28 | $1,125 | $34 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 12 | $1,057 | $59 |
| Protein measurement, body fluid | 50 | $944 | $17 |
| Pathology examination of tissue using a microscope, moderately low complexity | 48 | $584 | $11 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 11 | $570 | $41 |
| Pathology examination of specimen during surgery | 16 | $566 | $33 |
| Immunologic analysis technique on serum (immunofixation) | 27 | $557 | $16 |
| Pathology examination of specimen during surgery, each additional tissue block | 14 | $524 | $29 |
| Preparation of tissue for examination by removing any calcium present | 41 | $523 | $12 |
| Special stained specimen slides to examine tissue including interpretation and report | 29 | $416 | $11 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 20 | $351 | $17 |
| Pathology examination of tissue using a microscope, limited examination | 64 | $258 | $4 |
2014: 23 services
| Pathology examination of tissue using a microscope, intermediate complexity | 686 | $50,270 | $34 |
| Pathology examination of tissue using a microscope, moderately high complexity | 100 | $14,217 | $76 |
| Microscopic genetic analysis of tumor, manual | 67 | $8,416 | $49 |
| Protein measurement, serum | 245 | $6,988 | $17 |
| Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain | 170 | $6,008 | $28 |
| Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) | 118 | $5,568 | $11 |
| Special stained specimen slides to identify organisms including interpretation and report | 107 | $5,118 | $25 |
| Pathology examination of tissue using a microscope, high complexity | 38 | $5,109 | $134 |
| Evaluation of fine needle aspirate with interpretation and report | 38 | $3,750 | $65 |
| Pathology examination of specimen during surgery, first tissue block | 35 | $3,024 | $57 |
| Cell examination of specimen, selective cellular enhancement technique | 73 | $2,029 | $25 |
| Protein measurement, body fluid | 77 | $1,371 | $17 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 13 | $1,366 | $98 |
| Immunologic analysis technique on serum (immunofixation) | 56 | $931 | $16 |
| Evaluation of fine needle aspirate | 20 | $886 | $33 |
| Bone marrow, smear interpretation | 16 | $697 | $44 |
| Preparation of tissue for examination by removing any calcium present | 51 | $605 | $11 |
| Special stained specimen slides to examine tissue including interpretation and report | 36 | $563 | $11 |
| Pathology examination of specimen during surgery, each additional tissue block | 14 | $509 | $28 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 27 | $454 | $17 |
| Pathology examination of tissue using a microscope, moderately low complexity | 40 | $429 | $10 |
| Pathology examination of specimen during surgery | 13 | $424 | $33 |
| Pathology examination of tissue using a microscope, limited examination | 97 | $401 | $4 |
2013: 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 633 | $45,089 | $33 |
| Special stained specimen slides to examine tissue, initial procedure | 139 | $22,362 | $38 |
| Pathology examination of tissue using a microscope, moderately high complexity | 76 | $9,515 | $74 |
| Protein measurement, serum | 218 | $5,547 | $17 |
| Pathology examination of tissue using a microscope, high complexity | 36 | $4,854 | $131 |
| Microscopic genetic analysis of tumor, manual | 25 | $3,141 | $47 |
| Cell examination of specimen, selective cellular enhancement technique | 51 | $2,864 | $52 |
| Pathology examination of specimen during surgery, first tissue block | 30 | $2,634 | $56 |
| Special stained specimen slides to identify organisms including interpretation and report | 57 | $1,891 | $24 |
| Evaluation of fine needle aspirate with interpretation and report | 21 | $1,711 | $63 |
| Protein measurement, body fluid | 58 | $1,038 | $18 |
| Immunologic analysis technique on serum (immunofixation) | 58 | $1,013 | $17 |
| Pathology examination of tissue using a microscope, moderately low complexity | 49 | $514 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 38 | $447 | $11 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 23 | $431 | $18 |
| Evaluation of fine needle aspirate | 12 | $419 | $32 |
| Preparation of tissue for examination by removing any calcium present | 28 | $330 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 60 | $245 | $4 |
Medicaid work
$946 in 2024
Medicaid paid $946 for 37 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 37 | $946 |
| 2024 | 37 | 1 | 17 | $946 |
| 2022 | 11,509 | 39 | 340 | $3,938 |
| 2021 | 36,331 | 50 | 409 | $21,204 |
| 2020 | 26,677 | 43 | 306 | $33,691 |
| 2019 | 25,537 | 42 | 361 | $15,767 |
| 2018 | 27,112 | 42 | 337 | $13,846 |
See the largest Medicaid services in earlier years
2022
| COMPREHENSIVE METABOLIC PANEL | 1,750 | $679 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 2,054 | $597 |
| NFCT DS 22 TRGT SARS-COV-2 | 66 | $333 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 184 | $308 |
| Natriuretic peptide (heart and blood vessel protein) level | 176 | $200 |
| Troponin, quantitative | 479 | $169 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 511 | $160 |
| ASSAY OF LIPASE | 555 | $148 |
| Thyroid stimulating hormone (TSH) | 238 | $126 |
| Culture, bacterial; quantitative colony count, urine | 417 | $114 |
| BLOOD CULTURE FOR BACTERIA | 194 | $102 |
| Measurement of magnesium | 453 | $100 |
2021
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 376 | $5,689 |
| COMPREHENSIVE METABOLIC PANEL | 5,649 | $3,137 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 6,407 | $2,404 |
| ASSAY OF LIPASE | 1,744 | $735 |
| Troponin, quantitative | 1,429 | $671 |
| Culture, bacterial; quantitative colony count, urine | 1,250 | $627 |
| Thyroid stimulating hormone (TSH) | 761 | $606 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 512 | $599 |
| Natriuretic peptide (heart and blood vessel protein) level | 515 | $550 |
| Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism | 326 | $513 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 2,482 | $487 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe technique | 366 | $474 |
2020
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 908 | $17,286 |
| Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism | 869 | $2,568 |
| COMPREHENSIVE METABOLIC PANEL | 3,921 | $2,184 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 4,592 | $1,786 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe technique | 887 | $1,430 |
| Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, amplified probe technique | 885 | $1,425 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 162 | $872 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 198 | $776 |
| Troponin, quantitative | 1,096 | $472 |
| Thyroid stimulating hormone (TSH) | 544 | $452 |
| Natriuretic peptide (heart and blood vessel protein) level | 399 | $405 |
| ASSAY OF LIPASE | 1,119 | $382 |
2019
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 215 | $3,417 |
| TISSUE EXAM BY PATHOLOGIST | 113 | $2,589 |
| COMPREHENSIVE METABOLIC PANEL | 3,946 | $1,921 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 4,913 | $1,619 |
| Troponin, quantitative | 1,034 | $442 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 667 | $432 |
| Thyroid stimulating hormone (TSH) | 493 | $411 |
| Culture, bacterial; quantitative colony count, urine | 1,023 | $384 |
| Natriuretic peptide (heart and blood vessel protein) level | 377 | $370 |
| ASSAY OF LIPASE | 1,141 | $351 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 2,179 | $312 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe technique | 216 | $303 |
2018
| COMPREHENSIVE METABOLIC PANEL | 4,162 | $2,701 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 4,910 | $2,161 |
| TISSUE EXAM BY PATHOLOGIST | 67 | $837 |
| Thyroid stimulating hormone (TSH) | 623 | $695 |
| Culture, bacterial; quantitative colony count, urine | 1,219 | $632 |
| ASSAY OF LIPASE | 1,380 | $630 |
| Troponin, quantitative | 1,117 | $609 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 39 | $517 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 2,581 | $517 |
| Creatine kinase (CK), (CPK); MB fraction only | 756 | $486 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 886 | $416 |
| Natriuretic peptide (heart and blood vessel protein) level | 375 | $393 |
Money from drug and device companies
$21 in 2023
| 2023 | 1 | 1 | None | $21 |
| 2020 | 3 | 3 | None | $64 |
| 2019 | 9 | 17 | $466 | $755 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Hologic Sales and Service | Panther Fusion | $21 | 1 payment
|
See the published payment
| Hologic Sales and Service | Meals · 2023-03-17 | Panther Fusion | $21 |
See earlier years (2020, 2019)
2020: $64
| Blueprint Medicines | Ayvakit | $25 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $20 | 1 payment
|
| Novartis Pharmaceuticals | Tasigna | $20 | 1 payment
|
2019: $755
| Broncus Medical | None | $250 | 1 payment
|
| Boston Scientific | General Biliary Devices | $216 | 1 payment
|
| Novartis Pharmaceuticals | Votrient | $110 | 6 payments
|
| Merck Sharp & Dohme | Keytruda | $59 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | None | $51 | 2 payments
|
| Celgene | Revlimid | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $17 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $17 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Empliciti | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1720164775
- Licence
- CA G40301California G40301: Current · expires 2027-07-31
- Trained
- University of Chicago, Pritzker School of Medicine, 1978
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G403010
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X); Federal specialty code 207ZC0006X (207ZC0006X); Federal specialty code 207ZP0101X (207ZP0101X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-10-31
- NPI last updated
- 2024-03-14
- NPI record certified
- 2024-03-14
This is when the NPI record was last certified, not a medical board exam.